Table 1 Demographic data.

From: Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI

 

Parkinson’s disease patients (PD)

Healthy controls (HC)

Statistic

Total number (n)

23

23

 

Gender (male:female)

13:10

11:12

Chi-Square: df = 1; value = 0.3485; p = 0.5550

Age (years)

67.3 ± 9.9

67.7 ± 9.7

Two-sample t test; t (44) = −0.12, p = 0.90

Most affected side (right:left)

16:7

NA

 

Disease duration (years)

5.6 ± 3.8 [1–15]

NA

 

Hoehn and Yahr score

1.9 ± 0.6 [1–3]

NA

 

UPDRS III (motor)

28.2 ± 11.8 [10–54]

NA

 

LEDD (mg)

448.2 ± 286.8 [0–937]

NA

 
  1. Values represent the mean ± standard deviation [range] for disease duration, UPDRS III, Hoehn and Yahr score, and LEDD.
  2. UPDRS unified Parkinson’s disease rating score71, LEDD levodopa equivalent daily dose73.